CD28 and inflammatory bowel disease: Compared with MDSCs from healthy controls, MDSCs from IBD patients exhibited more powerful immunosuppressive function by expressing arginine-1 (Arg-1) and inhibiting the IFN-γ release of anti-CD3/CD28-stimulated autologous peripheral blood mononuclear cells in vitro.